Han BiomedicalROCO:6999 +0.17%25 Operating Margin % is 20.14% as of Dec. 2025, which is 16% below its 10-year median of 23.97. GuruFocus rates ROCO:6999 with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 936 Biotechnology companies, Han Biomedical ranks better than 87.5% on this metric.
Han Biomedical (ROCO:6999) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Han Biomedical Operating Margin % Related Terms
Han Biomedical Operating Margin % Historical Data
* Premium members only.
The historical data trend for Han Biomedical's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6999 vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Han Biomedical's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Han Biomedical Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Han Biomedical's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Han Biomedical's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Han Biomedical's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Han Biomedical (ROCO:6999) has a Operating Margin % of 20.14% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Han Biomedical and its competitors. This is 16% below median its historical median of 23.97. Over the past decade, Han Biomedical's Operating Margin % has ranged from 19.49 to 26.27. According to the industry distribution chart, Han Biomedical ranks #117 out of 936 companies in the Biotechnology industry, placing it in the top 12.5%.
Is Han Biomedical's Operating Margin % too high?
Han Biomedical's current Operating Margin % of 20.14% is 16% below median its 10-year median of 23.97. Over the past 10 years, this metric has ranged from a low of 19.49 to a high of 26.27. Based on the distribution chart, Han Biomedical ranks #117 out of 936 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Han Biomedical has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #117 out of 936 companies for Operating Margin %. This places Han Biomedical in the top 13% of its industry — outperforming the majority of peers. Historically, Han Biomedical's own Operating Margin % has ranged from 19.49 to 26.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Han Biomedical and its competitors. Han Biomedical's current Operating Margin % is 20.14%, which is 16% below median its own 10-year median of 23.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Operating Margin % of 20.14%. The current Operating Margin % is 20.14%, which is 16% below median its 10-year median of 23.97. Han Biomedical's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Operating Margin % is 20.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6999 has been successfully added to your 